Weicker R - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Discovery of New Anti-Cancer Agents against Patient-Derived Sorafenib-Resistant Papillary Thyroid Cancer.

Kim Y, Yun HJ, Choi KH, Kim CW, Lee JH, Weicker R, Kim SM, Park KC. Kim Y, et al. Among authors: weicker r. Int J Mol Sci. 2023 Nov 16;24(22):16413. doi: 10.3390/ijms242216413. Int J Mol Sci. 2023. PMID: 38003602 Free PMC article.

Potential Therapeutic Agents against Paclitaxel-And Sorafenib-Resistant Papillary Thyroid Carcinoma.

Kim SM, Park K, Lim JH, Yun HJ, Kim SY, Choi KH, Kim CW, Lee JH, Weicker R, Pan CH, Park KC. Kim SM, et al. Among authors: weicker r. Int J Mol Sci. 2022 Sep 8;23(18):10378. doi: 10.3390/ijms231810378. Int J Mol Sci. 2022. PMID: 36142303 Free PMC article.

Drug Discovery Using Evolutionary Similarities in Chemical Binding to Inhibit Patient-Derived Hepatocellular Carcinoma.

Lim JH, Park K, Choi KH, Kim CW, Lee JH, Weicker R, Pan CH, Kim SM, Park KC. Lim JH, et al. Among authors: weicker r. Int J Mol Sci. 2022 Jul 19;23(14):7971. doi: 10.3390/ijms23147971. Int J Mol Sci. 2022. PMID: 35887321 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters